CLG
Collplant
Stock
Stock
ISIN: IL0004960188
Ticker: CLGN
IL0004960188
CLGN
Price
Price
Frequently asked questions
What is Collplant's market capitalization?
The market capitalization of Collplant is $47.42M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Collplant?
Collplant's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.526. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Collplant's stock?
Currently, 1 analysts cover Collplant's stock, with a consensus target price of $11.00. Analyst ratings provide insights into the stock's expected performance.
What is Collplant's revenue over the trailing twelve months?
Over the trailing twelve months, Collplant reported a revenue of $689.00K.
What is the EBITDA for Collplant?
Collplant's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$17.31M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Collplant?
Collplant has a free cash flow of -$3.51M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of Collplant's stock?
The 5-year beta for Collplant is 0.50. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does Collplant have, and what sector and industry does it belong to?
Collplant employs approximately 75 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.
What is the free float of Collplant's shares?
The free float of Collplant is 7.82M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$47.42M5Y beta
0.50EPS (TTM)
-$1.526Free Float
7.82MRevenue (TTM)
$689.00KEBITDA (TTM)
-$17.31MFree Cashflow (TTM)
-$3.51MPricing
52W span
$3.31$6.99
Analyst Ratings
The price target is $11.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
75
Biotechnology & Drugs
Health Care
Identifier
ISIN
IL0004960188
Primary Ticker
CLGN